Side-by-side peptide comparisons.
Peptide Comparisons
The headline numbers invite a direct comparison that the evidence does not support. One is approved with head-to-head data; the other is phase 2 with none.
Peptide Library Editorial · Aug 31, 2026
Read article →
Peptide Comparisons
These are sold side by side and are not the same kind of thing. One of them has a documented liver injury signal.
Peptide Library Editorial · Aug 21, 2026
Read article →
Peptide Comparisons
Semax and Selank are constantly discussed together because they share an origin story, not a mechanism. One derives from ACTH, the other from an immune peptide, and the difference shows.
Peptide Library Editorial · Jun 9, 2026
Read article →
Peptide Comparisons
Semaglutide activates one receptor; tirzepatide activates two. In the first head-to-head trial the difference came out to 20.2% versus 13.7% body-weight reduction at 72 weeks. Here is what separates them.
Peptide Library Editorial · Apr 7, 2026
Read article →